KCNMB2 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84110
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human KCNMB2. Peptide sequence: QKCSYIPKCGKNFEESMSLVNVVMENFRKYQHFSCYSDPEGNQKSVILTK The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for KCNMB2 Antibody
Western Blot: KCNMB2 Antibody [NBP2-84110]
Western Blot: KCNMB2 Antibody [NBP2-84110] - Host: Rabbit. Target Name: KCNMB2. Sample Type: Lung Tumor lysates. Antibody Dilution: 1.0ug/mlApplications for KCNMB2 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: KCNMB2
Alternate Names
BK channel subunit beta-2, BKbeta2, calcium-activated potassium channel subunit beta-2, Calcium-activated potassium channel, subfamily M subunit beta-2, Charybdotoxin receptor subunit beta-2, Hbeta2, hbeta3, K(VCA)beta-2, large conductance calcium-activated potassium channel beta 2 subunit, large-conductance Ca2+-activated K+ channel beta2 subunit, Maxi K channel subunit beta-2, MaxiK channel beta 2 subunit, MGC22431, potassium large conductance calcium-activated channel, subfamily M, beta member2, Slo-beta-2
Gene Symbol
KCNMB2
Additional KCNMB2 Products
Product Specific Notices for KCNMB2 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...